Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXR | Stock Options (right to buy) | Award | $0 | +2.5K | $0.00 | 2.5K | Jul 15, 2024 | COMMON STOCK | 2.5K | $9.20 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Stock options granted on July 15, 2024 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan"). |
F2 | The stock options will vest in three installments on July 15, 2024 (833), July 15, 2025 (883) and July 15, 2026 (834) |